Posted in

Passion Flower (Passiflora incarnata)

Nomenclature & Taxonomic Classification

  • Botanical Binomial: Passiflora incarnata L.
  • Family: Passifloraceae
  • Common Name(s): Passionflower, Maypop, Purple Passionflower
  • Parts Used: Dried aerial parts (leaves, vines, flowers).

Botanical Description, Habitat & Sustainability

  • Physical Description: * Growth Habit: Perennial climbing or trailing vine.
    • Morphology: Alternate, deeply 3-lobed leaves with axillary tendrils. The striking flowers feature a white/pale lavender fringe or corona surrounding prominent central reproductive structures. Produces an ovoid, fleshy yellow berry (maypop).
  • Habitat & Cultivation: Native to the southeastern United States. Grows vigorously in fields, roadsides, and thickets. Prefers sandy, well-drained soils and full sun.
  • Sustainability Status: Secure; widely cultivated commercially.

Energetics & Traditional Actions

  • Western Tissue States: Corrects Irritation (heat/excitation) and Constriction (spasm/tension).
  • Traditional Vector:
    • Ayurveda: Rasa (Taste): Tikta (Bitter), Kashaya (Astringent) | Virya (Energy): Shita (Cooling) | Vipaka (Post-Digestive Effect): Katu | Dosha Modulation: Pacifies Pitta and Kapha; balances Vata in small doses, but can aggravate Vata if overused.
    • Traditional Chinese Medicine: Temperature: Cool | Taste: Bitter, Sour | Organ Meridians Entered: Heart, Liver.
  • Historical Folk Use: Used by Native American tribes (such as the Cherokee) as a topical anti-inflammatory and systemic social/nerve sedative.

Phytochemistry & Pharmacological Dynamics

  • Primary Phytochemicals: Flavonoids (chrysin, apigenin, vitexin, isovitexin), maltol, and trace indole alkaloids (harman, harmine).
  • Mechanism of Action: > Passiflora extracts bind directly to GABA-A receptors and inhibit GABA uptake in synapses, increasing central nervous system GABA concentrations. This down-regulates hyper-excitable neuronal pathways, calming the central nervous system without causing significant motor impairment or morning grogginess.

Clinical Applications & Indications

  • Primary Indications: Generalized anxiety disorder (GAD), nervous insomnia characterized by a circular, racing mind, muscle twitching, and tension headaches.
  • Secondary Indications: Neuralgia, cardiac palpitations due to anxiety, and supporting withdrawal protocols from nicotine, alcohol, or benzodiazepines.
  • Modern Clinical Evidence: Multiple randomized, double-blind controlled trials have demonstrated that Passiflora incarnata is as effective as oxazepam or midazolam in reducing generalized pre-operative and clinical anxiety scores.

Preparation, Dosing & Extraction Matrix

  • Optimal Menstruum & Extraction Guidelines: Infusion works well for mild sedative profiles; hydroethanolic extraction (40–50% EtOH) yields a highly reliable, bioavailable fraction of flavonoids and maltol.

Standard Dosage Parameters

Delivery MethodStandard Clinical DosageFrequency / Administration
Crude Herb Powder1–2 gramsAs needed or before bed
Infusion / Decoction1–2 tsp of dried herbInfused 15 mins covered; 3x daily or 1 hour before sleep
Tincture (1:5)2–5 mL3–4x daily or in a single large dose at night
Fluid Extract (1:1)1–2 mL2–3x daily

Safety Profile, Contraindications & Drug Interactions

  • Contraindications: Use with caution during pregnancy due to the traditional theoretical risk of uterine stimulation from trace indole alkaloids (though clinical evidence of harm is low).
  • Side Effects & Toxicity Thresholds: Exceptionally safe; mild drowsiness or hypersomnolence may occur at high doses.
  • Pharmaceutical Cross-Interactions: * Enzyme Alterations: Non-significant.
    • Additive Pathways: May synergistically potentiate the effects of CNS depressants, barbiturates, benzodiazepines, and SSRIs.

References

  1. Felter, H.W., & Lloyd, J.U. King’s American Dispensatory. (Eclectic usage).
  2. Bone, K. A Clinical Guide to Blending Liquid Herbs.
  3. Akhondzadeh, S., et al. (2001). “Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial.” Journal of Clinical Pharmacy and Therapeutics.